WASHINGTON, June 21 (Reuters) – The U.S. Supreme Court docket on Tuesday rejected Bayer AG’s (BAYGn.DE) bid to dismiss authorized claims by prospects who contend its Roundup weedkiller causes most cancers because the German firm seeks to keep away from probably billions of {dollars} in damages.
The justices turned away a Bayer attraction and left in place a decrease courtroom determination that upheld $25 million in damages awarded to California resident Edwin Hardeman, a Roundup person who blamed his most cancers on the pharmaceutical and chemical big’s glyphosate-based weedkillers.
The Supreme Court docket’s motion dealt a blow to Bayer as the corporate maneuvers to restrict its authorized legal responsibility in 1000’s of circumstances. The justices have a second Bayer petition pending on a associated subject that they may act upon within the coming weeks.
Bayer’s shares have been down 2.9% on the information, eliminating good points over the earlier two buying and selling periods.
U.S. President Joe Biden’s administration in Might urged the courtroom to not hear the Bayer attraction, reversing the federal government’s place beforehand taken underneath former President Donald Trump.
Bayer has misplaced three trials during which Roundup customers have been awarded tens of hundreds of thousands of {dollars} in every, whereas additionally successful 4 trials. Bayer had pinned hopes for aid on the conservative-majority Supreme Court docket, which has a status for being pro-business.
Bayer mentioned it “respectfully disagrees” with the courtroom’s determination and that the corporate is “totally ready to handle the litigation danger related to potential future claims within the U.S.”
On Friday, a federal appeals courtroom ordered the U.S. Environmental Safety Company (EPA) to take a recent have a look at whether or not the lively ingredient glyphosate poses unreasonable dangers to people and the atmosphere.
The San Francisco-based ninth U.S. Circuit Court docket of Appeals agreed with a number of environmental, farm employee and meals security advocacy teams that the EPA didn’t adequately think about whether or not glyphosate causes most cancers and threatens endangered species. learn extra
Bayer has requested the Supreme Court docket to evaluate the decision in Hardeman’s case, which was upheld by the ninth Circuit in Might 2021. Hardeman had often used Roundup for 26 years at his residence in northern California earlier than being recognized with a type of non-Hodgkin’s lymphoma.
Bayer mentioned in its March annual report that it had resolved about 107,000 circumstances out of about 138,000 circumstances total.
Bayer, which additionally makes aspirin, Yasmin birth-control capsules and the stroke prevention drug Xarelto amongst different merchandise, has argued that the most cancers claims over Roundup and glyphosate go in opposition to sound science and product clearance from the EPA.
The company has upheld steering that glyphosate just isn’t carcinogenic and never a danger to public well being when used as indicated on the label.
Bayer has mentioned it shouldn’t be penalized for advertising a product deemed secure by the EPA and on which the company wouldn’t enable a most cancers warning to be printed.
The lawsuits in opposition to Bayer have mentioned the corporate ought to have warned prospects of the alleged most cancers danger.
Roundup-related lawsuits have dogged Bayer because it acquired the model as a part of its $63 billion buy of agricultural seeds and pesticides maker Monsanto in 2018.
Bayer struck a settlement deal in precept with plaintiffs in June 2020 however did not win courtroom approval for a separate settlement on the best way to deal with future circumstances.
In July 2021, Bayer took an extra litigation provision of $4.5 billion in case of an unfavorable ruling by the Supreme Court docket or in case the justices declined to contemplate its attraction.
The supply got here on high of $11.6 billion it beforehand put aside for settlements and litigation over the matter.
Bayer plans to exchange glyphosate in weedkillers for the U.S. residential marketplace for non-professional gardeners with different lively substances.
Reporting by Lawrence Hurley; Further reporting by Ludwig Burger; Enhancing by Will Dunham
: .
